Sustainability & Climate

As federal funding for psychedelic therapy surges, practitioners warn that a critical lack of patient preparation and integration support could undermine healing.

AcreTrader's latest deal delivered big returns for investors and let a local family buy the land. Is this a new model for harmony or just a new land rush?

As SandRidge Energy reports Q1 results, investors watch to see if it capitalized on high oil prices while navigating a chaotic natural gas market.

With new strategic financing and powerhouse board appointments, 4D Path is accelerating its novel AI platform that predicts cancer treatment success from a single slide.

Promising data for its lead drug budoprutug has Climb Bio on a path to potentially redefine treatment for a range of debilitating autoimmune diseases.

On World Hand Hygiene Day, experts warn of waning habits post-pandemic. Discover the simple, life-saving power of a 20-second scrub and its huge impact.

Xali Gold is advancing its Pico Machay project in Peru, where vast gold potential at historically low prices meets a notoriously tough regulatory landscape.

A second major roof donation from Monarch Roofing provides a lifeline to All 4 Paws, highlighting a growing animal welfare crisis and a model for community support.

A breakthrough study validates a low-cost blood test that can detect multiple cancers and liver diseases, poised to transform preventative healthcare.

With $255M raised, Diagonal Therapeutics brings on a seasoned CFO to advance its novel antibody treatments for rare genetic diseases into the clinic.

A massive, 98-foot custom inflatable park debuts at Big Cedar Lodge, signaling a new era of deeply branded, immersive entertainment in the resort industry.

A new drug, CS-1103, earns FDA Fast Track to combat fentanyl overdoses by binding and removing the opioid, a potential game-changer over naloxone.

Archway Verdun was just crowned for its non-alcoholic creations, proving that Quebec's hospitality scene is embracing a mindful, inclusive future.

New data reveals 61% of LGBTQ+ youth report poor mental health, yet a near-unanimous 97% find powerful reasons for hope amidst the struggle.

A new geological report confirms gold potential at Treasure Canyon, but for a company with no revenue, the path to riches is paved with high risk.

As Strauss Group prepares its Q1 2026 results, investors are watching to see if strong 2025 momentum can overcome inflation and market shifts.

Telecom and tech titan Manoj Kohli joins Alt DRX's board, signaling that tokenized real estate is moving from speculation to a serious investment class.

Gauth launches its Live Tutor in Vietnam, promising to democratize education with AI. But can it overcome the digital divide and fierce local competition?

Beyond its first blockbuster, CRISPR Therapeutics reveals a deep pipeline for autoimmune and liver diseases, backed by a strong Q1 balance sheet.

The biotech's blockbuster Nasdaq debut provides crucial capital for its promising pipeline, offering new hope for patients with severe bleeding conditions.